Samarth Kulkarni, a Belgaumite recently assumed the role of CEO, Crispr Therapeutics a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases. Dr. Samarth Kulkarni, Ph.D. has been promoted to the role of Chief Executive Officer. And he will assume the role effective December 1, 2017. Dr. Rodger Novak, M.D., co-founder and current […]